JIVI

Product Overview

About JIVI

JIVI is a recombinant, B-domain deleted, pegylated antihaemophilic factor, used to treat and prevent bleeding in patients with haemophilia A. It is a medication designed to replace the deficient clotting factor VIII in the blood, thereby facilitating the blood's ability to clot and stop bleeding.

Key Benefits & Uses

• Treatment and prevention of bleeding episodes in patients with haemophilia A
• Management of bleeding in patients undergoing surgery or other invasive procedures
• Replacement therapy for patients with haemophilia A who have developed inhibitors to factor VIII

Active Ingredient & Action

ANTIHEMOPHILIC FACTOR (RECOMBINANT, B-DOMAIN DELETED, PEGYLATED) works by replacing the deficient clotting factor VIII in the blood, which is essential for the blood to clot and stop bleeding. This recombinant factor VIII is produced through a process of genetic engineering, ensuring a consistent and reliable supply of the medication.

Important Notes

It is essential to use JIVI exactly as prescribed by your healthcare provider. Inform your doctor about any allergies, medical conditions, or medications you are taking before starting treatment with JIVI. Regular monitoring of your blood clotting levels and platelet count is recommended to ensure the effectiveness and safety of the medication.